Christopher E. Mandigo

Dynamics of central and peripheral immunomodulation in a murine glioma model

Lisa M. Maier, Randy S. D’Amico, Christopher E. Mandigo et al. · BMC Immunology · 2009 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

Changes in the Immunologic Phenotype of Human Malignant Glioma Cells after Passaging in Vitro

Richard C. E. Anderson, J. Bradley Elder, Melandee Brown et al. · Clinical Immunology · 2002 · 45 citations

Medicine, Immunology, Oncology +12

Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells <i>in vitro</i> and <i>in vivo</i> by a p53 COOH-terminal peptide

Patrick B. Senatus, Li Yin, Christopher E. Mandigo et al. · Molecular Cancer Therapeutics · 2006 · 43 citations

Life Sciences, Cell Biology, Oncology +16

LACK OF B7 EXPRESSION, NOT HUMAN LEUKOCYTE ANTIGEN EXPRESSION, FACILITATES IMMUNE EVASION BY HUMAN MALIGNANT GLIOMAS

Richard C. E. Anderson, David E. Anderson, J. Bradley Elder et al. · Neurosurgery · 2007 · 42 citations

Medicine, Immunology, Oncology +16

Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1

Ruth Halaban, Enhao Cheng, Y Zhang et al. · Oncogene · 1998 · 35 citations

Life Sciences, Cell Biology, Molecular Biology +16